Advanced search×

Gene therapy: concepts and methods. Few applications so far.

Author(s) unavailable

Prescrire Int 18(104):276-9 (2009) PMID 20027718

(1) Gene therapy consists of inserting foreign genetic material into a patient's cells to correct a health disorder; (2) Only a fraction of gene therapy trials involve hereditary single-gene disorders. Most trials focus on acquired disorders such as cancer and cardiovascular disease; (3) The therapeutic gene can be delivered directly into the target organ or the general circulation, or alternatively into cells that are first isolated from the patient and then reinjected; (4) One of the main problems with gene therapy is finding an appropriate vector (viral or non-viral) that is both effective and safe. Most currently available vectors confer only weak and transient therapeutic gene expression. In addition, many carry major risks such as immunological disorders and oncogenicity; (5) In early 2009, only one therapeutic gene product is commercially available, in China.

Version: za2963e q8zad q8zba q8zc1 q8zd6 q8ze4 q8zf4 q8zge

Similar articles you may find interesting…

  1. Risperidone and lamotrigine: no evidence of a drug interaction.

    J Clin Psychiatry 67(7):1159 (2006) PMID 16889467

  2. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.

    J Clin Psychiatry 65(2):187-90 (2004) PMID 15003071

    Results suggest that low-dose cabergoline treatment of risperidone-induced hyperprolactinemia may be safe and clinically effective in a relevant number of patients....
  3. [Risperidone use in child and adolescent psychiatric patients].

    Therapie 63(5):359-75 (2008) PMID 19154706

    We have done a review of the literature on the effectiveness and the cautions for prescription of risperidone, a second generation antipsychotic drug. Risperidone has proved helpful in treating children and adolescents with autism spectrum, conduct and bipolar disorders, Tourette's syndrome, and sch...